Number of deaths in the UK due to blood clots after AstraZeneca jab rises to age 41

UK drug regulators said Thursday that 41 people died after developing blood clots after vaccination with the Oxford / AstraZeneca COVID-19 vaccine. This is an increase of 9 deaths from last week’s figures.

This was revealed on Thursday by the Medicines and Healthcare Products Regulatory Agency (MHRA). Updated weekly About side effects of CCP (Chinese Communist Party) virus vaccine based on data up to April 21.

The new data was released at a public show in support of the jab after British Health Minister Matt Hancock received the first dose of the AstraZeneca vaccine early Thursday.

A total of 209 thrombotic cases have been reported since vaccination with AstraZeneca injections, an increase of 41 from last week. MHRA said these events occurred in 120 women and 89 men between the ages of 18 and 93.

By April 21, the UK had given 22 million initial doses of AstraZeneca vaccine. Regulators say the overall incidence of blood clots is 9.3 per million.

“The benefits of vaccines outweigh the risks of the majority of people,” he said.

The AstraZeneca vaccine has been scrutinized for the problem of blood clots, with younger people having a higher incidence.

Last month, more than 12 European countries, including France, Germany, Italy and Spain, stopped using the AstraZeneca vaccine after reports of blood clots and the deaths of several people who were shot. Most countries have resumed vaccination, but some have suspended elderly vaccinations.

The European Medicines Agency (EMA), the European Union’s drug regulator, said on April 7 that there was a “potential link” between the AstraZeneca vaccine and “very rare” blood clots. He recommended continuing vaccination and emphasized that the benefits outweigh the risks.

Some Christians have expressed ethical concerns about the vaccine development process.

In an open letter to the so-called “vaccine passport” issued earlier this month, British church leaders said that some Christians had “a serious problem of ethics related to the ethics of vaccine production or testing.” I said there is.

The Oxford-AstraZeneca COVID-19 vaccine is an adenoviral vector vaccine developed from a 1973 aborted fetal-derived kidney cell line.

Jack Phillips and Reuters contributed to this report.

Posted on